Lipids & metabolic liver disease

Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease

Diabetes MetabPublished Retrospective cohort study

Main finding · Composite liver outcomeResult — go to the resultAdjusted hazard ratio 1.83 95% CI 1.38–2.41

Authors' conclusion

AKI was significantly associated with an increased risk of liver-related events among patients with MAFLD. These findings suggest that enhanced vigilance toward AKI may be justifiable in MAFLD patients.

Study context

Population
Chinese adults with MAFLD, China Renal Data System (CRDS) database; median age 59.17 years, 54.7% male
Participants
50,499 adults
Exposure
Acute kidney injury (AKI) vs no AKI during hospitalization
  • AKIn = 3,711
Outcome
Composite of:
  • Liver-related mortality
  • Major adverse liver outcomes

Main finding

Composite liver outcome

Adjusted hazard ratio

1.83

95% CI 1.38–2.41

P < 0.001

AKIvs No AKI
aHR 1.83 (95% CI 1.38–2.41); P < 0.001

As reported in the abstract

Patients with composite liver outcome (overall)
1,660 (3.3%)

Observational data: associations, not effects.

Secondary outcomes

OutcomeaHR (CI)P value
Composite liver outcome, severe AKI (stage 2/3)Severe AKI (stage 2/3)vs No AKI2.36 (1.57–3.54)P < 0.001
Escalation of FIB-4 risk scores1.28 (1.14–1.44)P < 0.001

Subgroups and sensitivity analyses

Associations remained consistent across various subgroups and sensitivity analyses

Original publication

Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease. Diabetes Metab. Published 16 March 2025. doi:10.1016/j.diabet.2025.101639

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.